ResearcherWest China Medical Center of Sichuan UniversityActive in the last 2 years

Tianfu Wen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1871-272X; OpenAlex author ID A5011926534. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wei Jun Peng · 2 shared papers, 2019–2024 · strength 0.35
- Paper Molecular characterization and prognostic relevance of m6A regulators in pancreatic adenocarcinoma DOI 10.21203/rs.3.rs-4948418/v1 ↗
- Paper MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS. DOI 10.1016/j.biopha.2019.109424 ↗
Mei Liu · 1 shared paper, 2024 · strength 0.23
- Paper Molecular characterization and prognostic relevance of m6A regulators in pancreatic adenocarcinoma DOI 10.21203/rs.3.rs-4948418/v1 ↗
Chuan Li · 1 shared paper, 2024 · strength 0.23
- Paper Molecular characterization and prognostic relevance of m6A regulators in pancreatic adenocarcinoma DOI 10.21203/rs.3.rs-4948418/v1 ↗
Fei Xie · 1 shared paper, 2019 · strength 0.12
- Paper MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS. DOI 10.1016/j.biopha.2019.109424 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.